{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:38:51Z","timestamp":1790293131888,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cca.2023.117420","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T18:56:35Z","timestamp":1685991395000},"page":"117420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Disease-Specific haptoglobin N-Glycosylation in inflammatory disorders between cancers and benign diseases of 3 types of female internal genital organs"],"prefix":"10.1016","volume":"547","author":[{"given":"Zhizhen","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1190-7949","authenticated-orcid":false,"given":"Zhili","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2023.117420_b0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.trstmh.2008.04.010","article-title":"Haptoglobin, inflammation and disease","volume":"102","author":"Quaye","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.cca.2023.117420_b0010","doi-asserted-by":"crossref","unstructured":"Gabay C. Interleukin-6 and chronic inflammation. Arthritis research & therapy 2006; 8 Suppl 2: S3. 2006. DOI: 10.1186\/ar1917.","DOI":"10.1186\/ar1917"},{"key":"10.1016\/j.cca.2023.117420_b0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1532\/IJH97.06141","article-title":"Regulation of neutrophil functions by proinflammatory cytokines","volume":"84","author":"Kato","year":"2006","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.cca.2023.117420_b0020","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cca.2023.117420_b0025","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","article-title":"RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics","volume":"28","author":"Best","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cca.2023.117420_b0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41551-018-0343-6","article-title":"Low-cost thermophoretic profiling of extracellular-vesicle surface proteins for the early detection and classification of cancers","volume":"3","author":"Liu","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.cca.2023.117420_b0035","doi-asserted-by":"crossref","unstructured":"Cristiano S, Leal A, Phallen J, et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature 2019; 570: 385-389. DOI: 10.1038\/s41586-019-1272-6.","DOI":"10.1038\/s41586-019-1272-6"},{"key":"10.1016\/j.cca.2023.117420_b0040","doi-asserted-by":"crossref","unstructured":"Pinho SS and Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nature reviews Cancer 2015; 15: 540-555. 2015\/08\/21. DOI: 10.1038\/nrc3982.","DOI":"10.1038\/nrc3982"},{"key":"10.1016\/j.cca.2023.117420_b0045","article-title":"In-depth investigation of altered glycosylation in human haptoglobin associated cancer by mass spectrometry","author":"Oh","year":"2021","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.cca.2023.117420_b0050","doi-asserted-by":"crossref","unstructured":"Cvetko A, Kifer D, Gornik O, et al. Glycosylation Alterations in Multiple Sclerosis Show Increased Proinflammatory Potential. Biomedicines 2020; 8 2020\/10\/18. DOI: 10.3390\/biomedicines8100410.","DOI":"10.3390\/biomedicines8100410"},{"key":"10.1016\/j.cca.2023.117420_b0055","doi-asserted-by":"crossref","unstructured":"Kawahara R, Recuero S, Srougi M, et al. The Complexity and Dynamics of the Tissue Glycoproteome Associated With Prostate Cancer Progression. Molecular & cellular proteomics : MCP 2021; 20: 100026. 2020\/11\/01. DOI: 10.1074\/mcp.RA120.002320.","DOI":"10.1074\/mcp.RA120.002320"},{"key":"10.1016\/j.cca.2023.117420_b0060","doi-asserted-by":"crossref","unstructured":"Silsirivanit A. Glycosylation markers in cancer. Advances in clinical chemistry 2019; 89: 189-213. 2019\/02\/25. DOI: 10.1016\/bs.acc.2018.12.005.","DOI":"10.1016\/bs.acc.2018.12.005"},{"key":"10.1016\/j.cca.2023.117420_b0065","doi-asserted-by":"crossref","unstructured":"Zhang S, Shang S, Li W, et al. Insights on N-glycosylation of human haptoglobin and its association with cancers. Glycobiology 2016; 26: 684-692. 2016\/02\/14. DOI: 10.1093\/glycob\/cww016.","DOI":"10.1093\/glycob\/cww016"},{"key":"10.1016\/j.cca.2023.117420_b0070","doi-asserted-by":"crossref","unstructured":"Zhu J, Wu J, Yin H, et al. Mass Spectrometric N-Glycan Analysis of Haptoglobin from Patient Serum Samples Using a 96-Well Plate Format. Journal of proteome research 2015; 14: 4932-4939. 2015\/10\/09. DOI: 10.1021\/acs.jproteome.5b00662.","DOI":"10.1021\/acs.jproteome.5b00662"},{"key":"10.1016\/j.cca.2023.117420_b0075","doi-asserted-by":"crossref","unstructured":"Chen T, He C, Zhang M, et al. Disease-specific haptoglobin-\u03b2 chain N-glycosylation as biomarker to differentiate non-small cell lung cancer from benign lung diseases. Journal of Cancer 2019; 10: 5628-5637. 2019\/11\/19. DOI: 10.7150\/jca.32690.","DOI":"10.7150\/jca.32690"},{"key":"10.1016\/j.cca.2023.117420_b0080","doi-asserted-by":"crossref","unstructured":"Fujita K, Shimomura M, Uemura M, et al. Serum fucosylated haptoglobin as a novel prognostic biomarker predicting high-Gleason prostate cancer. The Prostate 2014; 74: 1052-1058. 2014\/05\/08. DOI: 10.1002\/pros.22824.","DOI":"10.1002\/pros.22824"},{"key":"10.1016\/j.cca.2023.117420_b0085","doi-asserted-by":"crossref","unstructured":"Dalal K, Dalal B, Bhatia S, et al. Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection. Clinica chimica acta; international journal of clinical chemistry 2019; 495: 309-32019\/04\/25. DOI: 10.1016\/j.cca.2019.04.072.","DOI":"10.1016\/j.cca.2019.04.072"},{"key":"10.1016\/j.cca.2023.117420_b0090","doi-asserted-by":"crossref","unstructured":"Lee SH, Jeong S, Lee J, et al. Glycomic profiling of targeted serum haptoglobin for gastric cancer using nano LC\/MS and LC\/MS\/MS. Molecular bioSystems 2016; 12: 3611-3621. 2016\/11\/04. DOI: 10.1039\/c6mb00559d.","DOI":"10.1039\/C6MB00559D"},{"key":"10.1016\/j.cca.2023.117420_b0095","doi-asserted-by":"crossref","unstructured":"Carlsson MC, Cederfur C, Schaar V, et al. Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients. PloS one 2011; 6: e26560. 2011\/10\/27. DOI: 10.1371\/journal.pone.0026560.","DOI":"10.1371\/journal.pone.0026560"},{"key":"10.1016\/j.cca.2023.117420_b0100","doi-asserted-by":"crossref","unstructured":"Lin Z, Simeone DM, Anderson MA, et al. Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer. Journal of proteome research 2011; 10: 2602-2611. 2011\/03\/23. DOI: 10.1021\/pr200102h.","DOI":"10.1021\/pr200102h"},{"key":"10.1016\/j.cca.2023.117420_b0105","doi-asserted-by":"crossref","unstructured":"Takeda Y, Shinzaki S, Okudo K, et al. Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer. Cancer 2012; 118: 3036-3043. 2011\/10\/19. DOI: 10.1002\/cncr.26490.","DOI":"10.1002\/cncr.26490"},{"key":"10.1016\/j.cca.2023.117420_b0110","doi-asserted-by":"crossref","unstructured":"Song G, Liu Y, Wang Y, et al. Personalized biomarkers to monitor disease progression in advanced non-small-cell lung cancer patients treated with icotinib. Clinica chimica acta; international journal of clinical chemistry 2015; 440: 44-48. 2014\/12\/03. DOI: 10.1016\/j.cca.2014.11.010.","DOI":"10.1016\/j.cca.2014.11.010"},{"key":"10.1016\/j.cca.2023.117420_b0115","doi-asserted-by":"crossref","unstructured":"Liu Y, Zhang D, Cheng Y, et al. Elevated serum immunoinflammation-related protein complexes are associated with psychosis. Psychiatry research 2015; 230: 96-101. 2015\/09\/05. DOI: 10.1016\/j.psychres.2015.08.029.","DOI":"10.1016\/j.psychres.2015.08.029"},{"key":"10.1016\/j.cca.2023.117420_b0120","doi-asserted-by":"crossref","unstructured":"Wang Y, Song G, Wang Y, et al. Elevated serum levels of circulating immunoinflammation-related protein complexes are associated with cancer. Journal of proteome research 2014; 13: 710-719. 2013\/12\/04. DOI: 10.1021\/pr4008255.","DOI":"10.1021\/pr4008255"},{"key":"10.1016\/j.cca.2023.117420_b0125","doi-asserted-by":"crossref","unstructured":"Lai Z, Zhang M, Zhou J, et al. Fe(3)O(4)@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides. The Analyst 2021; 146: 4261-4267. 2021\/06\/10. DOI: 10.1039\/d1an00580d.","DOI":"10.1039\/D1AN00580D"},{"key":"10.1016\/j.cca.2023.117420_b0130","doi-asserted-by":"crossref","unstructured":"Barry MJ. Screening for prostate cancer--the controversy that refuses to die. The New England journal of medicine 2009; 360: 1351-1354. 2009\/03\/20. DOI: 10.1056\/NEJMe0901166.","DOI":"10.1056\/NEJMe0901166"},{"key":"#cr-split#-10.1016\/j.cca.2023.117420_b0135.1","doi-asserted-by":"crossref","unstructured":"Ebeling FG, Stieber P, Untch M, et al. Serum CEA and CA 15-3 as prognostic factors in primary breast cancer. British journal of cancer 2002","DOI":"10.1038\/sj.bjc.6600248"},{"key":"#cr-split#-10.1016\/j.cca.2023.117420_b0135.2","doi-asserted-by":"crossref","unstructured":"86: 1217-1222. 2002\/04\/16. DOI: 10.1038\/sj.bjc.6600248.","DOI":"10.1038\/sj.bjc.6600248"},{"key":"10.1016\/j.cca.2023.117420_b0140","doi-asserted-by":"crossref","unstructured":"Zurawski VR, Jr., Orjaseter H, Andersen A, et al. Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. International journal of cancer 1988; 42: 677-680. 1988\/11\/15. DOI: 10.1002\/ijc.2910420507.","DOI":"10.1002\/ijc.2910420507"},{"key":"10.1016\/j.cca.2023.117420_b0145","doi-asserted-by":"crossref","unstructured":"Zhang D, Li X, Liu X, et al. Disease-Specific IgG Fc Glycosylation Ratios as Personalized Biomarkers to Differentiate Non-Small Cell Lung Cancer from Benign Lung Diseases. Proteomics Clinical applications 2020; 14: e1900016. 2019\/11\/11. DOI: 10.1002\/prca.201900016.","DOI":"10.1002\/prca.201900016"},{"key":"10.1016\/j.cca.2023.117420_b0150","doi-asserted-by":"crossref","unstructured":"Lee J, Hua S, Lee SH, et al. Designation of fingerprint glycopeptides for targeted glycoproteomic analysis of serum haptoglobin: insights into gastric cancer biomarker discovery. Analytical and bioanalytical chemistry 2018; 410: 1617-1629. 2017\/12\/DOI: 10.1007\/s00216-017-0811-y.","DOI":"10.1007\/s00216-017-0811-y"},{"key":"10.1016\/j.cca.2023.117420_b0155","doi-asserted-by":"crossref","unstructured":"Zhang Y, Zhu J, Yin H, et al. ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis. Journal of proteome research 2015; 14: 5388-5395. 2015\/10\/28. DOI: 10.1021\/acs.jproteome.5b00792.","DOI":"10.1021\/acs.jproteome.5b00792"},{"key":"10.1016\/j.cca.2023.117420_b0160","doi-asserted-by":"crossref","unstructured":"Zhang Z, Wuhrer M and Holst S. Serum sialylation changes in cancer. Glycoconjugate journal 2018; 35: 139-160. 2018\/04\/24. DOI: 10.1007\/s10719-018-9820-0.","DOI":"10.1007\/s10719-018-9820-0"},{"key":"10.1016\/j.cca.2023.117420_b0165","doi-asserted-by":"crossref","unstructured":"Colotta F, Allavena P, Sica A, et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009; 30: 1073-1081. 2009\/05\/27. DOI: 10.1093\/carcin\/bgp127.","DOI":"10.1093\/carcin\/bgp127"},{"key":"10.1016\/j.cca.2023.117420_b0170","doi-asserted-by":"crossref","unstructured":"Takahashi S, Sugiyama T, Shimomura M, et al. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer. Glycoconjugate journal 2016; 33: 471-482. 2016\/02\/13. DOI: 10.1007\/s10719-016-9653-7.","DOI":"10.1007\/s10719-016-9653-7"},{"key":"10.1016\/j.cca.2023.117420_b0175","doi-asserted-by":"crossref","unstructured":"Ma J, Sanda M, Wei R, et al. Quantitative analysis of core fucosylation of serum proteins in liver diseases by LC-MS-MRM. Journal of proteomics 2018; 189: 67-74. 2018\/02\/11. DOI: 10.1016\/j.jprot.2018.02.003.","DOI":"10.1016\/j.jprot.2018.02.003"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812300222X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812300222X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:09:09Z","timestamp":1757862549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989812300222X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":36,"alternative-id":["S000989812300222X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117420","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease-Specific haptoglobin N-Glycosylation in inflammatory disorders between cancers and benign diseases of 3 types of female internal genital organs","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117420"}}